Brought to you by 
Amer. Cyanamid gets dexfenfluramine from Interneuron
13 Jul 1999
Executive Summary
Cyanamid licensed dexfenfluramine (obesity treatment) from Interneuron Pharmaceuticals, which had licensed it from Servier, which markets it outside of US.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Co-Promotion
- Includes Contract
- Includes Equity
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Amer. Cyanamid gets dexfenfluramine from Interneuron
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice